Health Condition 1: K80-K87- Disorders of gallbladder, biliary tract and pancreas Health Condition 2: K808- Other cholelithiasis
Conditions
Interventions
Intervention1: Erector Spinae Plane Block: Patients will receive ESPB with 20ml 0.25% ropivacaine bilaterally before surgery
after induction of anaesthesia.
Control Intervention1: Erector Spinae Plane
Sponsors
Prithibiraj Ahanthem
Eligibility
Inclusion criteria
Inclusion criteria: Patients of American Society of Anaesthesiologists (ASA) physical grade I or II.
Exclusion criteria
Exclusion criteria: 1. Patient with hypertension 2. Diabetes mellitus with neuropathy 3. Deranged liver and renal function 4. Conversion to open cholecystectomy 5. Patients with known allergy to local anaesthetic drugs 6. Infection at injection site 7. Bleeding disorders
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the effect of ultrasound guided erector spinae plane block, in attenuation of stress response to pneumoperitoneum and intraoperative opioid consumption in patient undergoing laparoscopic cholecystectomyTimepoint: Total amount of fentanyl consumed during intraoperatively and the response of haemodynamic parameters (Heart Rate, Mean Arterial Pressure) during time of port insertion and at 5 min, 10 min, after pneumoperitoneum stretch, will be recorded.Outcome will be assessed starting from the point of administration of study drugs till 60 minutes post pneumoperitoneum. Data will then be assessed at the end of one year. | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate adverse reactions such as hypotension, bradycardia and local anaesthetic toxicity.Timepoint: Outcome will be assessed starting from the point of administration of study drugs till 30 minutes post extubation. Data will then be assessed at the end of one year. | — |
Countries
India
Contacts
Public ContactDr N Ratan Singh
Regional Institute of Medical Sciences, Imphal
Outcome results
None listed